Jin Seok Kim

Daratumumab-Based Treatment for Immunoglobulin Light-Chain Amyloidosis

Efstathios Kastritis, Giovanni Palladini, Monique C. Minnema et al. · New England Journal of Medicine · 2021 · 609 citations · Full text

A prognostic index for natural killer cell lymphoma after non-anthracycline-based treatment: a multicentre, retrospective analysis

Seok Jin Kim, Dok Hyun Yoon, Arnaud Jaccard et al. · The Lancet Oncology · 2016 · 375 citations · Full text

Lymphoid Neoplasia, Oncology, Retrospective Analysis +7

Natural history of relapsed myeloma, refractory to immunomodulatory drugs and proteasome inhibitors: a multicenter IMWG study

Shaji Kumar, Meletios Α. Dimopoulos, Efstathios Kastritis et al. · Leukemia · 2017 · 348 citations · Full text

Hematological Malignancy, Proteasome Inhibitors, Relapsed Myeloma +10

Phase II Trial of Concurrent Radiation and Weekly Cisplatin Followed by VIPD Chemotherapy in Newly Diagnosed, Stage IE to IIE, Nasal, Extranodal NK/T-Cell Lymphoma: Consortium for Improving Survival of Lymphoma Study

Seok Jin Kim, Byung‐Soo Kim, Chul Yong Kim et al. · Journal of Clinical Oncology · 2009 · 340 citations · Full text

Polyethylene glycol-grafted poly-l-lysine as polymeric gene carrier

Young Hun Choi, Feng Liu, Jin Seok Kim et al. · Journal of Controlled Release · 1998 · 337 citations

Engineering, Biofabrication, Gene Delivery +2